Corpus Intelligence IC Memo — TRUSTPOINT HOSPITAL 2026-04-26 07:38 UTC
IC Memo — TRUSTPOINT HOSPITAL
Investment Committee Memorandum | TN | 18 beds | Grade D | EBITDA uplift $3.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TRUSTPOINT HOSPITAL

CCN 440231 | RUTHERFORD, TN | 18 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

TRUSTPOINT HOSPITAL is a 18-bed community hospital in RUTHERFORD, TN with $50.8M in net patient revenue and a -0.8% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.0% Medicaid, and 100.0% commercial.

Thesis: Turnaround. Our ML models identify $3.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.8% to 6.6% (+736bps).

Net Revenue HCRIS$50.8M
Current EBITDA COMPUTED$-388K
Operating Margin COMPUTED-0.8%
Occupancy HCRISnan%
Revenue / Bed COMPUTED$2.8M
Net-to-Gross HCRIS29.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
39
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -0.8% places it below the state median. Among 39 size-comparable peers (9-36 beds), the median margin is -0.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TRUSTPOINT HOSPITAL (Target)TN18$50.8M-0.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
VANDERBILT BEDFORD COUNTY HOSPTN24$49.5M1.9%
NEWPORT MEDICAL CENTERTN32$47.8M11.6%
FORT LOUDOUN MEDICAL CENTERTN30$41.3M10.0%
CLAIBORNE MEDICAL CENTERTN26$30.9M-9.9%
MARSHALL MEDICAL CENTERTN25$29.5M-28.0%
DELTA MEDICAL CENTER MEMPHISTN10$28.4M3.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.1M+210bp18mo
Cost to Collect4.5%2.5%$1.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$619K+122bp9mo
Clean Claim Rate88.0%96.0%$33K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.1M
Cost to Collect
$1.0M
Denial Rate Reduction
$1.0M
A/R Days Reduction
$619K
Clean Claim Rate
$33K
Total EBITDA Uplift$3.7M
Current EBITDA$-388K
+ RCM Uplift+$3.7M
Pro Forma EBITDA$3.4M
Current Margin-0.8%
Pro Forma Margin6.6%
WC Released (1x)$2.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-597K$34.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-597K$38.2M0.00x-100.0%
Bull Case9.0x11.0x$-538K$50.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-538K$54.7M0.00x-100.0%
Bear Case11.0x10.0x$-657K$16.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-657K$17.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 9-36 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-16.7% / P50=-0.6% / P75=9.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.